Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (SHE:301617)
China · Delayed Price · Currency is CNY 53.00
+1.00 (1.92%)
At close: Jun 2, 2026
SHE:301617 Revenue
Shandong Boyuan Pharmaceutical & Chemical had revenue of 391.13M CNY in the quarter ending March 31, 2026, with 22.14% growth. This brings the company's revenue in the last twelve months to 1.54B, up 14.57% year-over-year. In the year 2025, Shandong Boyuan Pharmaceutical & Chemical had annual revenue of 1.46B with 10.30% growth.
Revenue (ttm)
1.54B
Revenue Growth
+14.57%
P/S Ratio
6.00
Revenue / Employee
2.05M
Employees
748
Market Cap
9.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.46B | 136.80M | 10.30% |
| Dec 31, 2024 | 1.33B | 302.73M | 29.53% |
| Dec 31, 2023 | 1.03B | 226.68M | 28.39% |
| Dec 31, 2022 | 798.47M | 274.10M | 52.27% |
| Dec 31, 2021 | 524.37M | 144.93M | 38.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TECON BIOLOGY Co.LTD | 16.72B |
| Xinjiang Communications Construction Group | 9.52B |
| Suofeiya Home Collection | 8.85B |
| Shanghai Yct Electronics Group Co.,Ltd | 7.47B |
| Guangdong Goworld | 6.43B |
| De Rucci Healthy Sleep | 5.29B |
| Sunvim Group Co.,Ltd | 5.26B |
| Tofflon Science and Technology Group | 5.20B |